Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis.
Andreas Strasser(The University of Melbourne), Suzanne Cory(The University of Melbourne), David C.S. Huang(Indonesia International Institute for Life Sciences), Peter H. Krammer(Slovak Academy of Sciences), A. W. Harris(The Royal Melbourne Hospital)
Cited by 788
Related Papers
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Death and anti-death: tumour resistance to apoptosis
|Nature reviews. Cancer|2002|2.1k
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
|Science|1989|1.7k